<qa>  What is the potential therapeutic benefit of adding TH-302 to the standard doxorubiThe current study is designed to assess the potential therapeutic benefit of adding TH-302 to the standard doxorubicin based TACE regimen in patients with advanced hepatocellular carcinomas. 